Co-Diagnostics Shares Drop After New Resale Filing
Co-Diagnostics shares fell 21% to $6.71 in early Nasdaq trading Monday after the SEC declared effective a resale registration for up to 4.94 million shares from a May private placement. The company said it will not receive proceeds from share resales but could get up to $5.18 million if warrants are exercised. The stock traded between $5.11 and $10.18 during the session.
